| | | | | | | | | | | | | | | |
| |
 | Issue Date FY: 2022 ( Subtotal = $0 ) |
| 2022 | 2021 | COLLABORATIVE DRUG DISCOVERY INC | 1633 BAYSHORE HWY | BURLINGAME | CA | 94010 | SAN MATEO | USA | National Center for Advancing Translational Sciences | 000 | 3 | 7/26/2022 | NON-COMPETING CONTINUATION | $0 |
|
 | Issue Date FY: 2021 ( Subtotal = $750,747 ) |
| 2021 | 2021 | COLLABORATIVE DRUG DISCOVERY, INC. | 1633 BAYSHORE HWY STE 342 | BURLINGAME | CA | 94010 | SAN MATEO | USA | National Center for Advancing Translational Sciences | 000 | 3 | 12/15/2020 | NON-COMPETING CONTINUATION | $750,747 |
|
 | Issue Date FY: 2020 ( Subtotal = $748,733 ) |
| 2020 | 2020 | COLLABORATIVE DRUG DISCOVERY, INC. | 1633 BAYSHORE HWY STE 342 | BURLINGAME | CA | 94010 | SAN MATEO | USA | National Center for Advancing Translational Sciences | 000 | 2 | 12/18/2019 | COMPETING CONTINUATION | $748,733 |
|
|